drugset / Trial / NCT02387580

Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets

NCT02387580

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-centre, 2-part, randomised, single-dose parallel group study in healthy male subjects and female subjects of non-childbearing potential.

Timeline

Start
2015-04
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artefenomel Small molecule 800 mg Oral
Background PQP Unknown 960 mg Oral

Indications